174 related articles for article (PubMed ID: 34990827)
1. What is the prevalence of drug use in the general population? Simulating underreported and unknown use for more accurate national estimates.
Levy NS; Palamar JJ; Mooney SJ; Cleland CM; Keyes KM
Ann Epidemiol; 2022 Apr; 68():45-53. PubMed ID: 34990827
[TBL] [Abstract][Full Text] [Related]
2. Underreporting of past-year cannabis use on a national survey by people who smoke blunts.
Le A; Han BH; Palamar JJ
Subst Abus; 2022; 43(1):349-355. PubMed ID: 34214396
[No Abstract] [Full Text] [Related]
3. Discrepancies in estimates of prevalence and correlates of substance use and disorders between two national surveys.
Grucza RA; Abbacchi AM; Przybeck TR; Gfroerer JC
Addiction; 2007 Apr; 102(4):623-9. PubMed ID: 17309538
[TBL] [Abstract][Full Text] [Related]
4. Estimating the Prevalence of Substance Use Disorders in the US Using the Benchmark Multiplier Method.
Mojtabai R
JAMA Psychiatry; 2022 Nov; 79(11):1074-1080. PubMed ID: 36129721
[TBL] [Abstract][Full Text] [Related]
5. Underreporting of drug use among electronic dance music party attendees.
Palamar JJ; Salomone A; Keyes KM
Clin Toxicol (Phila); 2021 Mar; 59(3):185-192. PubMed ID: 32644026
[TBL] [Abstract][Full Text] [Related]
6. Exploring the perils of cross-national comparisons of drug prevalence: The effect of survey modality.
Giommoni L; Reuter P; Kilmer B
Drug Alcohol Depend; 2017 Dec; 181():194-199. PubMed ID: 29080406
[TBL] [Abstract][Full Text] [Related]
7. Trends and correlates of discordant reporting of drug use among nightclub/festival attendees, 2019-2022.
Palamar JJ; Salomone A
Clin Toxicol (Phila); 2023 Sep; 61(9):665-673. PubMed ID: 37988115
[TBL] [Abstract][Full Text] [Related]
8. Cannabis use prevalence among individuals with diabetes: The National Survey on Drug Use and Health, 2005-2018.
Sexton TR; Alshaarawy O
Drug Alcohol Depend; 2020 Jul; 212():108035. PubMed ID: 32470752
[TBL] [Abstract][Full Text] [Related]
9. Estimated probability of becoming a case of drug dependence in relation to duration of drug-taking experience: a functional analysis approach.
Vsevolozhskaya OA; Anthony JC
Int J Methods Psychiatr Res; 2017 Jun; 26(2):. PubMed ID: 27356948
[TBL] [Abstract][Full Text] [Related]
10. Hypertension: development of a prediction model to adjust self-reported hypertension prevalence at the community level.
Mentz G; Schulz AJ; Mukherjee B; Ragunathan TE; Perkins DW; Israel BA
BMC Health Serv Res; 2012 Sep; 12():312. PubMed ID: 22967264
[TBL] [Abstract][Full Text] [Related]
11. Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting.
Palamar JJ; Martins SS; Su MK; Ompad DC
Drug Alcohol Depend; 2015 Nov; 156():112-119. PubMed ID: 26377051
[TBL] [Abstract][Full Text] [Related]
12. Self-Reported Substance Use With Clinician Interviewers Versus Self-Administered Surveys.
Gorfinkel L; Stohl M; Shmulewitz D; Hasin D
J Stud Alcohol Drugs; 2024 Jan; 85(1):92-99. PubMed ID: 37796626
[TBL] [Abstract][Full Text] [Related]
13. Trends in cocaine use among United States females of reproductive age, 2005-2019.
Orndorff M; Shipp GM; Kerver JM; Ondersma SJ; Alshaarawy O
Am J Addict; 2024 May; 33(3):313-319. PubMed ID: 37924245
[TBL] [Abstract][Full Text] [Related]
14. Validity of self-reported substance use in men who have sex with men: comparisons with a general population sample.
Fendrich M; Mackesy-Amiti ME; Johnson TP
Ann Epidemiol; 2008 Oct; 18(10):752-9. PubMed ID: 18693041
[TBL] [Abstract][Full Text] [Related]
15. Heroin use cannot be measured adequately with a general population survey.
Reuter P; Caulkins JP; Midgette G
Addiction; 2021 Oct; 116(10):2600-2609. PubMed ID: 33651441
[TBL] [Abstract][Full Text] [Related]
16. Co-occurrence across time and space of drug- and cannabinoid- exposure and adverse mental health outcomes in the National Survey of Drug Use and Health: combined geotemporospatial and causal inference analysis.
Reece AS; Hulse GK
BMC Public Health; 2020 Nov; 20(1):1655. PubMed ID: 33148213
[TBL] [Abstract][Full Text] [Related]
17. The replicability of cannabis use prevalence estimates in the United States.
Alshaarawy O; Anthony JC
Int J Methods Psychiatr Res; 2017 Jun; 26(2):. PubMed ID: 27658846
[TBL] [Abstract][Full Text] [Related]
18. Estimating the prevalence of drug use from self-reports in a cohort for which biologic data are available for a subsample.
Poole WK; Flynn PM; Rao AV; Cooley PC
Am J Epidemiol; 1996 Aug; 144(4):413-20. PubMed ID: 8712199
[TBL] [Abstract][Full Text] [Related]
19. Cigarette use is increasing among people with illicit substance use disorders in the United States, 2002-14: emerging disparities in vulnerable populations.
Weinberger AH; Gbedemah M; Wall MM; Hasin DS; Zvolensky MJ; Goodwin RD
Addiction; 2018 Apr; 113(4):719-728. PubMed ID: 29265574
[TBL] [Abstract][Full Text] [Related]
20. Trends and correlates of cocaine use among adults in the United States, 2006-2019.
Mustaquim D; Jones CM; Compton WM
Addict Behav; 2021 Sep; 120():106950. PubMed ID: 33940336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
